784
Views
25
CrossRef citations to date
0
Altmetric
Reviews

Influenza vaccines: from whole virus preparations to recombinant protein technology

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Velasco Cimica, Jose M Galarza, Sujatha Rashid & Timothy T. Stedman. (2021) Current development of Zika virus vaccines with special emphasis on virus-like particle technology. Expert Review of Vaccines 20:11, pages 1483-1498.
Read now
Nisreen M. A. Okba, Ivy Widjaja, Brenda van Dieren, Andrea Aebischer, Geert van Amerongen, Leon de Waal, Koert J. Stittelaar, Debby Schipper, Byron Martina, Judith M. A. van den Brand, Martin Beer, Berend-Jan Bosch & Bart L. Haagmans. (2020) Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV. Emerging Microbes & Infections 9:1, pages 1080-1091.
Read now

Articles from other publishers (23)

Rehan Haider. (2023) Vaccine through Centuries. Major Cornerstone of Global Health. Asian Journal of Pharmacy and Technology, pages 65-69.
Crossref
E. Redondo, I. Rivero-Calle, E. Mascarós, J.E. Yuste, M. Fernández-Prada, D. Ocaña, I. Jimeno, A. Gil, J. Molina, J.L. Díaz-Maroto, M. Linares & F. Martinón-Torres. (2021) Vacunación frente a la neumonía adquirida en la comunidad del adulto. Actualización 2021 del posicionamiento del Grupo de Neumoexpertos en Prevención. Medicina de Familia. SEMERGEN 47:6, pages 411-425.
Crossref
Muhammad Umer Ashraf, Yeji Kim, Sunil Kumar, Dongyeob Seo, Maryam Ashraf & Yong-Soo Bae. (2021) COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform. Vaccines 9:2, pages 171.
Crossref
Hitesh Kumar Dewangan. (2020) Rational application of nanoadjuvant for mucosal vaccine delivery system. Journal of Immunological Methods 481-482, pages 112791.
Crossref
Pragya Misra & Shailza Singh. 2020. Systems and Synthetic Immunology. Systems and Synthetic Immunology 1 52 .
Guozhong He, Pengfei Yang, Qingli Yan & Chenglong Xiong. (2019) Debate on the compositions of influenza B in northern hemisphere seasonal influenza vaccines. Antimicrobial Resistance & Infection Control 8:1.
Crossref
Sean A. Nelson & Andrea J. Sant. (2019) Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus. Frontiers in Immunology 10.
Crossref
Ralf Wagner & Eberhard Hildt. (2019) Zusammensetzung und Wirkmechanismen von Adjuvanzien in zugelassenen viralen ImpfstoffenComposition and mode of action of adjuvants in licensed viral vaccines. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 62:4, pages 462-471.
Crossref
E. Redondo, I. Rivero-Calle, D.A. Vargas, E. Mascarós, J.L. Díaz-Maroto, M. Linares, A. Gil, J. Molina, I. Jimeno, D. Ocaña, J.E. Yuste & F. Martinón-Torres. (2018) Vacunación frente a la neumonía adquirida en la comunidad del adulto. Actualización 2018 del posicionamiento del Grupo de Neumoexpertos en Prevención. Medicina de Familia. SEMERGEN 44:8, pages 590-597.
Crossref
Rashmirekha Pati, Maxim Shevtsov & Avinash Sonawane. (2018) Nanoparticle Vaccines Against Infectious Diseases. Frontiers in Immunology 9.
Crossref
Raffael Nachbagauer & Peter Palese. (2018) Development of next generation hemagglutinin-based broadly protective influenza virus vaccines. Current Opinion in Immunology 53, pages 51-57.
Crossref
A. García, M. Fernández-Prada, J. Aristegui, D. Moreno, E. Redondo, I. Jimeno, M. García Cenoz & J.A. Lopez Trigo. (2018) Executive summary of the update and reflection document on influenza vaccination in Spain. Vacunas (English Edition) 19:2, pages 85-98.
Crossref
A. García, M. Fernández-Prada, J. Aristegui, D. Moreno, E. Redondo, I. Jimeno, M. García Cenoz & J.A. Lopez Trigo. (2018) Resumen ejecutivo del documento de actualización y reflexión sobre vacunación antigripal en España. Vacunas 19:2, pages 85-98.
Crossref
Velasco Cimica & Jose M. Galarza. (2017) Adjuvant formulations for virus-like particle (VLP) based vaccines. Clinical Immunology 183, pages 99-108.
Crossref
Eugenio J. Abente, Jefferson Santos, Nicola S. Lewis, Phillip C. Gauger, Jered Stratton, Eugene Skepner, Tavis K. Anderson, Daniela S. Rajao, Daniel R. Perez & Amy L. Vincent. (2016) The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus. Journal of Virology 90:18, pages 8266-8280.
Crossref
Yong-Dae Gwon, Sehyun Kim, Yeondong Cho, Yoonki Heo, Hansam Cho, Kihoon Park, Hee-Jung Lee, Jiwon Choi, Haryoung Poo & Young Bong Kim. (2016) Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1. PLOS ONE 11:5, pages e0154824.
Crossref
Sang-Hee Sim, Joo Young Kim, Baik Lin Seong, Huan Huu Nguyen & Jun Chang. (2016) Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice. PLOS ONE 11:3, pages e0152485.
Crossref
Karen K. Yam, Jyotsana Gupta, Elizabeth K. Allen, Kayla R. Burt, Édith Beaulieu, Corey P. Mallett, David S. Burt & Brian J. Ward. (2016) Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice. Vaccine 34:12, pages 1444-1451.
Crossref
Shin-ichi Tamura, Akira Ainai, Tadaki Suzuki, Takeshi Kurata & Hideki Hasegawa. (2016) Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?. Japanese Journal of Infectious Diseases 69:3, pages 165-179.
Crossref
Neal A. Halsey, Kawsar R. Talaat, Adena Greenbaum, Eric Mensah, Matthew Z. Dudley, Tina Proveaux & Daniel A. Salmon. (2015) The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper. Vaccine 33, pages F1-F67.
Crossref
Stanley Plotkin. (2014) History of vaccination. Proceedings of the National Academy of Sciences 111:34, pages 12283-12287.
Crossref
Han Zhang, Li Wang, Richard Compans & Bao-Zhong Wang. (2014) Universal Influenza Vaccines, a Dream to Be Realized Soon. Viruses 6:5, pages 1974-1991.
Crossref
Sanjay Kapoor & Kuldeep DhamaSanjay Kapoor & Kuldeep Dhama. 2014. Insight into Influenza Viruses of Animals and Humans. Insight into Influenza Viruses of Animals and Humans 163 216 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.